ABOS Acumen Pharmaceuticals Inc

$ABOS Yet another anti- B amyloid antiody fails. But they had $78M in cash at the end of September, that is 5X the current market cap. The Enhanced Brain Delivery (ABD platform) has value. A reverse merger for stock shell and cash, license or sale of EBD platform/ or in-license deal for new pipeline will capture the value of that cash. Having cash in hand these dark biotech days is more valuable than the cash itself. With no active programs, the cash burn rate will plummet. They have about $25M liabilities on balance sheet besides long term debt that will have to be paid. This stock is worth about $50M, about 3X the current market cap.

$ABOS l believe the 90% crash is an overreaction driven by panic selling. Acumen is NOT finished! Three reasons remain for optimism: EBD Technology: Sabirnetug failed, but Acumen's EBD technology and two remaining candidates still have potential. JCR Partnership: The existing collaboration creates opportunities for further development, licensing, or strategic deals. Cash Reserves: Acumen still has $78.6 million in cash and marketable securities to support its next steps. One failed trial does not make an entire company worthless. The market may be overlooking the technology, partnership, and financial resources Acumen still has. This is a major setback, not necessarily the end Regards ,

$ABOS -89% is a bit much unless for any company minus those going bankrupt. There will be a bounce. I'm paytient. Pretty sure we'll see the $.41-.$43 soon

$ABOS There's a very promising non-antibody drug for Alzheimer's over at $ANVS - get in at all-time lows before their phase 3 trial results in March... (graph is ADAS-Cog phase 2 results in mild Alz patients)

$ABOS current MC, 15M cash on hand 75M+ do the math folks, I’m loading every dip presented!! Feel free to spread the word!! $NTCL $LABT $OMH

$ABOS They have plenty of cash. This is extremely over sold. They aren’t shutting down or anything.

$ABOS added 28k shares at .23 . Nice green candles should happen soon before close.... i hope...

$ABOS Its a steal at this price level as they have 70m cash whereas MC is 20m. lol. Hey Market, you're so stupid.😀

$ABOS charts got me bullish bought more, establishing a floor at .24 for more upward movement 🤞

$ABOS this stock went from 2.30 to .22 in one day.... so your saying there is chance we can go back to .50s to .80s maybe

$ABOS $PMN I think… There are now many opportunities that are much less risky than these zombies stock that suddenly jump from the swamps.

$ABOS Whether your buy is 22c, 25c, 30c, i think this will rebound atleast 50-100% from here. 66 percent institutional ownership,. 62$ cash / share. Both $TENX & $SION bounced 80% or more from lows. Just be patient.

$ABOS $PMN isnt it amazing, a week ago abos was so bullish about sabirnetug and their pipeline and a week later both are history

$ABOS if the scrap value here is substantially more than .20 we'll likely see a Tang filing saying he acquired over 5%

Acumen wiped out: $ABOS crashed 86% to $0.33 today after its Alzheimer drug failed its Phase 2 trial. The company scrapped its only drug and is now exploring strategic options.

$ABOS ONLY OVER 9% LEFT TO BE 100% DOWN!! COMMON YOU DUMB AND SCUM CEO.... YOU CAN RUIN THIS WITH THE FLYING COLORS!!!!!!

$ABOS Easiest money you will ever make at this price. They have plenty of cash. It will go back up.

$ABOS these boys are well paid. Perhaps time to take a cut in pay until you can prove yourself.

$ABOS So far to analysts' positive view on reward/risk setup for topline data in NOV, we may see $3-4 before the topline, IMO.

$ABOS $PMN Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in November 2026